Zoekresultaten - 8 results

Prevalence of drug use before and during imprisonment in seven European countries (2014–2018)

people in prison before and during incarceration in seven European countries and to compare it with the prevalence in the general population. Individual data collection was carried out between 2014 and ...

Prevalence of drug use before and during imprisonment in seven European countries (2014-2018)

This study aimed to describe the prevalence of drug use among people in prison before and during incarceration in seven European countries and to compare it with the prevalence in the general population. ...

Use of general health care by people with substance use disorders in Belgium (2008-2017)

Publication Type: Peer reviewed scientific article Authors: L Van Baelen; Brecht Devleesschauwer; Karin De Ridder; E Plettinckx; L. Gremeaux Source: European Journal of Public Health, Volume 30, ...

Synthetic Cannabinoids and Cannabis: How the Patterns of Use Differ: Results from the European Web Survey on Drugs

characteristics, and use of other drugs differ among people who only use cannabis and those that use synthetic cannabinoids. Data from the second wave of the European Web Survey on Drugs, a web-based cross-sectional ...

Cocaine treatment demands in 10 western European countries: observed trends between 2011 and 2018

Publication Type: Peer reviewed scientific article Authors: Jérôme Antoine; Nadine Berndt; Mariana Astudillo; Donal Cairns; Stefan Jahr; Andrew Jones; Kuijpers, Wil; Noelia Llorens; Suzi Lyons; Etienne Maffli; Natalia Magliocchetti; Marta Molina Olivas; C ...

Is there a relation between cannabis use and being a victim of violence in the general population?

Publication Type: Peer reviewed scientific article Authors: E Plettinckx; Sabine Drieskens; Jérôme Antoine; Lydia Gisle Source: European Journal of Public Health, Volume 27, Issue suppl_3 (2017) ...

Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study.

gabapentin has been licensed in the European Union only for neuropathic pain and epilepsy for patients who have partial seizures, it has also been prescribed in treatment for substance use disorders. Many ...

Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol.

(TDI) is gathering this information at European level since 2000. In Belgium, this registration started at national level in 2011 and an increasing number of facilities of different types are ...

QR code

QR code for this page URL